• Publications
  • Influence
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), a new measure of depressive symptom severity derived from the 30-item Inventory of Depressive Symptomatology (IDS), is available inExpand
  • 2,271
  • 306
The Inventory of Depressive Symptomatology (IDS): psychometric properties.
The psychometric properties of the 28- and 30-item versions of the Inventory of Depressive Symptomatology, Clinician-Rated (IDS-C) and Self-Report (IDS-SR) are reported in a total of 434 (28-item)Expand
  • 1,666
  • 160
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
OBJECTIVE Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are notExpand
  • 2,669
  • 133
  • PDF
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
OBJECTIVE This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives toExpand
  • 2,480
  • 129
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
BACKGROUND Patients with chronic forms of major depression are difficult to treat, and the relative efficacy of medications and psychotherapy is uncertain. METHODS We randomly assigned 681 adultsExpand
  • 1,207
  • 53
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report
Background. The present study provides additional data on the psychometric properties of the 30-item Inventory of Depressive Symptomatology (IDS) and of the recently developed Quick Inventory ofExpand
  • 731
  • 52
Exercise treatment for depression: efficacy and dose response.
BACKGROUND This study, conducted between 1998 and 2001 and analyzed in 2002 and 2003, was designed to test (1) whether exercise is an efficacious treatment for mild to moderate major depressiveExpand
  • 1,159
  • 50
  • PDF
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
BACKGROUND After unsuccessful treatment for depression with a selective serotonin-reuptake inhibitor (SSRI), it is not known whether switching to one antidepressant is more effective than switchingExpand
  • 848
  • 35
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
OBJECTIVE About half of outpatients with major depressive disorder also have clinically meaningful levels of anxiety. The authors conducted a secondary data analysis to compare antidepressantExpand
  • 608
  • 34
Medication augmentation after the failure of SSRIs for depression.
BACKGROUND Although clinicians frequently add a second medication to an initial, ineffective antidepressant drug, no randomized controlled trial has compared the efficacy of this approach. METHODSExpand
  • 866
  • 30
...
1
2
3
4
5
...